JP2007519640A5 - - Google Patents

Download PDF

Info

Publication number
JP2007519640A5
JP2007519640A5 JP2006549182A JP2006549182A JP2007519640A5 JP 2007519640 A5 JP2007519640 A5 JP 2007519640A5 JP 2006549182 A JP2006549182 A JP 2006549182A JP 2006549182 A JP2006549182 A JP 2006549182A JP 2007519640 A5 JP2007519640 A5 JP 2007519640A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
halo
orx
nrxrx
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006549182A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007519640A (ja
JP4762917B2 (ja
Filing date
Publication date
Priority claimed from SE0400021A external-priority patent/SE0400021D0/xx
Priority claimed from SE0400585A external-priority patent/SE0400585D0/xx
Application filed filed Critical
Priority claimed from PCT/SE2004/002034 external-priority patent/WO2005066131A1/en
Publication of JP2007519640A publication Critical patent/JP2007519640A/ja
Publication of JP2007519640A5 publication Critical patent/JP2007519640A5/ja
Application granted granted Critical
Publication of JP4762917B2 publication Critical patent/JP4762917B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006549182A 2004-01-08 2004-12-30 非ヌクレオシド逆転写酵素インヒビター Expired - Fee Related JP4762917B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0400021-2 2004-01-08
SE0400021A SE0400021D0 (sv) 2004-01-08 2004-01-08 Non-nucleoside reverse transcriptase inhibitors
SE0400585A SE0400585D0 (sv) 2004-03-09 2004-03-09 NNRTI Antivirals
SE0400585-6 2004-03-09
PCT/SE2004/002034 WO2005066131A1 (en) 2004-01-08 2004-12-30 Non-nucleotide reverse transcriptase inhibitors

Publications (3)

Publication Number Publication Date
JP2007519640A JP2007519640A (ja) 2007-07-19
JP2007519640A5 true JP2007519640A5 (https=) 2008-01-24
JP4762917B2 JP4762917B2 (ja) 2011-08-31

Family

ID=34752289

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006549182A Expired - Fee Related JP4762917B2 (ja) 2004-01-08 2004-12-30 非ヌクレオシド逆転写酵素インヒビター

Country Status (15)

Country Link
US (1) US7915295B2 (https=)
EP (1) EP1701942B1 (https=)
JP (1) JP4762917B2 (https=)
AT (1) ATE451357T1 (https=)
AU (1) AU2004312284B2 (https=)
BR (1) BRPI0418306B8 (https=)
CA (1) CA2550187C (https=)
DE (1) DE602004024584D1 (https=)
DK (1) DK1701942T3 (https=)
EA (1) EA009700B1 (https=)
ES (1) ES2337794T3 (https=)
IL (1) IL176740A (https=)
NZ (1) NZ548367A (https=)
SG (1) SG149070A1 (https=)
WO (1) WO2005066131A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1534276B1 (en) * 2002-09-05 2008-11-05 Medivir AB Non-nucleoside reverse transcriptase inhibitors
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
WO2006114001A1 (en) * 2005-04-27 2006-11-02 Ambrilia Biopharma Inc. Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors
ES2452718T3 (es) 2005-11-30 2014-04-02 Taimed Biologics, Inc. Profármacos a base de lisina de inhibidores de la aspartil proteasa y procesos para su preparación
GB0608876D0 (en) * 2006-05-05 2006-06-14 Medivir Ab Combination therapy
EP2021327B1 (en) * 2006-05-15 2012-04-04 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
CA2664118A1 (en) 2006-09-21 2008-07-03 Ambrilia Biopharma Inc. Protease inhibitors
WO2016123387A1 (en) * 2015-01-30 2016-08-04 Genentech, Inc. Therapeutic compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69916425T2 (de) 1998-01-16 2005-05-19 Medivir Ab Antivirale mittel
WO1999051613A1 (en) * 1998-04-03 1999-10-14 Medivir Ab Prodrugs of phosphorous-containing pharmaceuticals
SE0100733D0 (sv) * 2001-03-05 2001-03-05 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
SE0102867D0 (sv) 2001-08-28 2001-08-28 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
EP1534276B1 (en) 2002-09-05 2008-11-05 Medivir AB Non-nucleoside reverse transcriptase inhibitors

Similar Documents

Publication Publication Date Title
EP2552902B1 (en) Non-nucleoside reverse transcriptase inhibitors
JP2021519783A5 (https=)
JP2022545359A5 (https=)
DK2298747T3 (en) TRIAZOLD DERIVATIVES OR SALTS THEREOF
US20020016328A1 (en) Corticotropin releasing factor antagonists
CN109790135B (zh) 用于治疗或预防与痛风或高尿酸血症相关的症状的化合物、组合物和方法
JP2019529490A5 (https=)
US7807684B2 (en) HIV reverse transcriptase inhibitors
JP2024001048A5 (https=)
WO2007037534A1 (ja) 2-へテロアリール置換インドール誘導体
TW200524935A (en) Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
JP2014510774A5 (https=)
TW200813013A (en) N-(amino-heteroaryl)-1H-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
TW201021798A (en) Amide acetate derivative having inhibitory activity on endothelial lipase
TW200813010A (en) Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors
ZA200502384B (en) Non-nucleoside reverse transcriptase inhibitors
JP2019518050A5 (https=)
JPWO2002072145A1 (ja) Ep1アンタゴニストを有効成分として含有するうつ病の治療剤
JP2020533352A5 (https=)
WO1996032384A1 (en) Novel 4,6-diarylpyrimidine derivatives and salts thereof
JP2024515062A (ja) 重水素化dhodh阻害剤
JP2025538389A (ja) グルカゴン様ペプチド1受容体アゴニスト
JP2007519640A5 (https=)
RU2007108863A (ru) Производные пиразола для лечения состояний, опосредованных активацией рецептора аденозина а2в или а3
TW202237146A (zh) 使用腺苷衍生物及衣殼抑制劑之hiv組合療法